Home
Philosophy
Portfolio
Team
Scientific Advisory Board
Ray Dolby’s Legacy
News
Contact
MindImmune Therapeutics Announces $12.4 million Series A Financing
Comments are closed.
Technology and business giants David Dolby and Mark Knickrehm join Salk’s Board
AccuKnox Raises $6M in Seed Funding for Zero Trust CNAPP and KubeArmor OpenSource Project
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Eargo Is The Hearing Aid Of The Future